Search

Late-Breaking Abstract Submission

Late-breaking abstract procedureThe official late-breaking abstract submission will open from May 3 to 9, 2024 (09:00 CEST). The full late-breaking abstract submission terms & conditions can be found here.

Read more

First CMML guidelines produced by EHA, now available

Chronic myelomonocytic leukemia (CMML) is a rare disease with overlapping features of two categories of bone marrow and blood cell disorders that poses challenges in clinical management.

Read more

Moldova to be allowed to participate in EU4Health projects

The European Commission and the Government of the Republic of Moldova have signed an agreement to associate Moldova with the EU4Health program.

Read more

EHA Meeting Hub

 

Know about the EHA Meeting Hub
  
Meet with your fellow colleagues and further your work in person in Madrid.

Read more

EHA Research Conference 2024

Dates: March 18-21, 2024
Location: Borovets, Bulgaria
Chairs: Anna Kabanova, Martina Muckenthaler, Andreas Trumpp, Simon Haas, Jean-Emmanuel Sarry, Achille Iolascon, Britta Will and Brian Huntly

Registration is closed

EHA is proud to announce the second edition of the EHA Research Conference, titled "Molecular vulnerabilities and…

Read more

Novel basis for chemoresistance in AML: DNMT3A R882 mutations promote chemoresistance and residual disease through impaired DNA damage sensing

Although most acute myeloid leukemia (AML) patients initially respond to chemotherapy, the majority subsequently relapses and succumbs to refractory disease. Residual leukemic cells that survived chemotherapy may persist over time and later cause the disease to come back.

Read more